Dr. Catherine Pallen

Principal Investigator

Ph.D. [Medical Biochemistry] (University of Calgary)
Associate Member, Department of Pathology and Laboratory Medicine, University of British Columbia
Professor, Division of Hematology and Oncology, Department of Pediatrics, University of British Columbia

Research Interests

; ; ;

Dr. Pallen is not accepting summer students for 2016.

Myelin is a protective coating that ensheathes the nerve fibers (termed axons) which carry information to and from the brain. Its main purpose is to enhance the speed of impulse conduction and to protect axons from unnecessary damage. Myelin can be impaired from traumatic injury or also from diseases like multiple sclerosis and leukodystrophy. In such cases, loss of myelin can lead to paralysis, loss of sensation, of learning impairments; however, work is being done to understand how myelin can be regenerated (a process termed re-myelination) which may help alleviate these negative outcomes.

Dr. Catherine Pallen is highly regarded for her research on cell signaling and understanding the role and mechanism by which a molecule called PTPa (protein tyrosine phosphatase alpha) influences myelination. Her work has shown that PTPa is required for normal growth and maturation of myelin-producing cells and she has developed experimental models to investigate how PTPa functions for myelin repair.

Another area of her research is focused on understanding pain pathways and finding better treatments based on cellular regulation. PTPa is known to be involved in integrin signaling (cell receptors essential for cell processes) and because site-specific phosphorylation of PTP molecules is poorly understood, its role in cell migration, development, survival and immune activation is still being studied.  Furthermore, PTPa has been linked to the function of a pain-mediating receptor (N-methyl-D-aspartate, NMDA) and could lead to improved treatments for long-term persistent pain.

Techniques employed in the labs:

  • Cell culturing
  • Transfection of plasmids and small-interfering RNA
  • Immunoblot Assays
  • Peptide Microarrays

Current Lab Members

Masters Students Post-Doctoral Fellows
Yuda Shih Dr. Philip Ly

Trainee Awards

Year Name Award
2014 Dr. Philip Ly
  • Postdoctoral Fellowship Award (Canadian Institutes of Health Research)
  • Trainee Travel Grant (Child & Family Research Institute)
  • Postdoctoral Fellowship Award (Child & Family Research Institute) [declined]
  • Postdoctoral Fellowship Award (Multiple Sclerosis Society of Canada)

Current Opportunities in the Lab

Please contact Dr. Pallen with inquiries.

Recent publications

  • Khanna, RS, Le, HT, Wang, J, Fung, TC, Pallen, CJ. 2015. The interaction of protein-tyrosine phosphatase α (PTPα) and RACK1 protein enables insulin-like growth factor 1 (IGF-1)-stimulated Abl-dependent and -independent tyrosine phosphorylation of PTPα.. J. Biol. Chem. doi: 10.1074/jbc.M114.624247.
  • Geldman, A, Pallen, CJ. 2015. Protein tyrosine phosphatases in mast cell signaling.. Methods Mol. Biol. doi: 10.1007/978-1-4939-1568-2_17.
  • Cheng, SY, Sun, G, Schlaepfer, DD, Pallen, CJ. 2014. Grb2 promotes integrin-induced focal adhesion kinase (FAK) autophosphorylation and directs the phosphorylation of protein tyrosine phosphatase α by the Src-FAK kinase complex.. Mol. Cell. Biol. doi: 10.1128/MCB.00825-13.
  • Fam, HK et al.. 2013. TDP1 and PARP1 deficiency are cytotoxic to rhabdomyosarcoma cells.. Mol. Cancer Res. doi: 10.1158/1541-7786.MCR-12-0575.
  • Meyer, DS et al.. 2014. Tyrosine phosphatase PTPα contributes to HER2-evoked breast tumor initiation and maintenance.. Oncogene. doi: 10.1038/onc.2012.585.
Search PubMed